
Joseph Weiss Jr.
Examiner (ID: 16737)
| Most Active Art Unit | 3761 |
| Art Unit(s) | 3761, 3743, 3735 |
| Total Applications | 359 |
| Issued Applications | 252 |
| Pending Applications | 58 |
| Abandoned Applications | 49 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14276995
[patent_doc_number] => 20190135782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FERROPTOSIS AND TREATING EXCITOTOXIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/247354
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/247354 | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders | Jan 13, 2019 | Issued |
Array
(
[id] => 18216390
[patent_doc_number] => 11591312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Halogenation of pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/961949
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9452
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961949 | Halogenation of pyridine derivatives | Jan 13, 2019 | Issued |
Array
(
[id] => 19135799
[patent_doc_number] => 11970731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Enhancement of nucleic acid polymerization by aromatic compounds
[patent_app_type] => utility
[patent_app_number] => 16/959985
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 31825
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959985 | Enhancement of nucleic acid polymerization by aromatic compounds | Dec 26, 2018 | Issued |
Array
(
[id] => 14213681
[patent_doc_number] => 20190119225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/230634
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/230634 | Heterocyclic compound | Dec 20, 2018 | Issued |
Array
(
[id] => 18451759
[patent_doc_number] => 20230193038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS OF DIGITAL PRINTING USING MODIFIED INDIGO COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/956145
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956145 | METHODS OF DIGITAL PRINTING USING MODIFIED INDIGO COMPOUNDS | Dec 19, 2018 | Abandoned |
Array
(
[id] => 14743717
[patent_doc_number] => 20190255032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => 2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
[patent_app_type] => utility
[patent_app_number] => 16/218829
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/218829 | 2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders | Dec 12, 2018 | Abandoned |
Array
(
[id] => 15946021
[patent_doc_number] => 10660888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Aminoheteroaryl benzamides as kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/210968
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 109497
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16210968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/210968 | Aminoheteroaryl benzamides as kinase inhibitors | Dec 4, 2018 | Issued |
Array
(
[id] => 16913868
[patent_doc_number] => 20210186960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
[patent_app_type] => utility
[patent_app_number] => 16/768287
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768287 | MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE | Dec 4, 2018 | Abandoned |
Array
(
[id] => 15984449
[patent_doc_number] => 10672560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Electro-polarizable compound and capacitor
[patent_app_type] => utility
[patent_app_number] => 16/208953
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5807
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208953 | Electro-polarizable compound and capacitor | Dec 3, 2018 | Issued |
Array
(
[id] => 18384482
[patent_doc_number] => 11655251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Method for the production of lumateperone and its salts
[patent_app_type] => utility
[patent_app_number] => 16/767057
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28199
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767057 | Method for the production of lumateperone and its salts | Nov 26, 2018 | Issued |
Array
(
[id] => 16297665
[patent_doc_number] => 20200283388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => PROCESS FOR THE PREPARATION OF FLUOPICOLIDE
[patent_app_type] => utility
[patent_app_number] => 16/765763
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765763 | Process for the preparation of fluopicolide | Nov 20, 2018 | Issued |
Array
(
[id] => 14072213
[patent_doc_number] => 20190084994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => HEPATITIS B ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/194608
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194608 | Hepatitis B antiviral agents | Nov 18, 2018 | Issued |
Array
(
[id] => 18013270
[patent_doc_number] => 11505552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Method for isolation of cytisine
[patent_app_type] => utility
[patent_app_number] => 16/965790
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2151
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965790 | Method for isolation of cytisine | Nov 18, 2018 | Issued |
Array
(
[id] => 18216389
[patent_doc_number] => 11591311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
[patent_app_type] => utility
[patent_app_number] => 16/765806
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26230
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765806 | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides | Nov 15, 2018 | Issued |
Array
(
[id] => 18134709
[patent_doc_number] => 11560362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Dibutylfluorene derivative and application thereof as photoinitiator
[patent_app_type] => utility
[patent_app_number] => 16/765826
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765826 | Dibutylfluorene derivative and application thereof as photoinitiator | Nov 11, 2018 | Issued |
Array
(
[id] => 16379513
[patent_doc_number] => 20200328356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => ORGANIC PHOTOVOLTAIC CELLS AND NON-FULLERENE ACCEPTORS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/761914
[patent_app_country] => US
[patent_app_date] => 2018-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761914 | Organic photovoltaic cells and non-fullerene acceptors thereof | Nov 4, 2018 | Issued |
Array
(
[id] => 16420529
[patent_doc_number] => 20200345727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/761390
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 162315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761390 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Nov 1, 2018 | Abandoned |
Array
(
[id] => 16452515
[patent_doc_number] => 20200361941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/761386
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 173103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -85
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761386 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Nov 1, 2018 | Abandoned |
Array
(
[id] => 18544174
[patent_doc_number] => 11717505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas
[patent_app_type] => utility
[patent_app_number] => 16/768827
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 6857
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768827 | Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas | Nov 1, 2018 | Issued |
Array
(
[id] => 13986233
[patent_doc_number] => 20190062274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/175144
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175144 | Heterocyclic compound | Oct 29, 2018 | Issued |